Target intelligence / Profile preview

Glutamic-oxaloacetic transaminase 2 pseudogene 3 (GOT2P3)

Target
GOT2P3
Molecular classification
Pseudogene
01

Overview

Glutamic-oxaloacetic transaminase 2 pseudogene 3 (GOT2P3) is a processed pseudogene in the human genome. Unlike protein-coding genes, pseudogenes are incomplete copies or variants of functional genes that have lost their protein-coding ability due to accumulating mutations. Most pseudogenes, including GOT2P3, do not produce functional proteins and are not directly involved in cellular biochemical functions. While some pseudogenes can have roles in gene regulation via non-coding RNAs, there is currently no evidence supporting significant biological or clinical relevance for GOT2P3. This molecule is not considered a drug target or a biomarker in clinical practice. GOT2P3 is distinct from its parental functional gene, GOT2, which encodes mitochondrial aspartate aminotransferase; the pseudogene does not retain enzymatic activity because it is not translated into protein. As a pseudogene, GOT2P3 may potentially participate in gene regulation as a non-coding RNA, but such roles remain hypothetical unless experimentally validated. There are no known gene products, molecular pathways, or clinical outcomes definitively associated with GOT2P3.

Other names
GOT2L3GOT2L3Pglutamic-oxaloacetic transaminase 2 pseudogene 3glutamic-oxaloacetic transaminase 2-like 3 pseudogeneglutamic-oxaloacetic transaminase 2-like pseudogeneGOT2P3
02

Biological functions

No established protein-coding functionTypical for pseudogenes
03

Disease associations

No direct, validated disease associationFunctional pseudogenes can sometimes affect gene regulation by acting as non-coding RNAs, but specific roles for GOT2P3 are unknown

Beyond the preview

Go deeper on Glutamic-oxaloacetic transaminase 2 pseudogene 3 (GOT2P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutamic-oxaloacetic transaminase 2 pseudogene 3 (GOT2P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call